PAI-1, an inflammatory adipokine and a recognized biomarker of metabolic syndrome [40,41], is closely associated with cardiovascular disease, hepatic steatosis, dyslipidemia, and adipose tissue dysfunction [42,43,44]. Here, SERPINE1 is linked to cardiovascular disorder.